Akebia Therapeutics to Report Second Quarter 2024 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics (Nasdaq: AKBA) has announced plans to release its financial results for the second quarter of 2024 on Thursday, August 8, 2024, before the financial markets open. The company will host a conference call at 8:00 a.m. ET on the same day to discuss the results and recent business highlights.
Investors and interested parties can access the call by dialing (800) 715-9871 (USA & Canada - Toll-Free) and entering Conference ID: 4155557. Additionally, a live webcast of the conference call will be available through the Investors section of Akebia's website at https://ir.akebia.com/. An online archive of the webcast will also be accessible via the same section of the company's website.
Akebia Therapeutics (Nasdaq: AKBA) ha annunciato i suoi piani per pubblicare i risultati finanziari del secondo trimestre del 2024 giovedì 8 agosto 2024, prima dell'apertura dei mercati finanziari. L'azienda ospiterà una chiamata in conferenza alle 8:00 ET lo stesso giorno per discutere i risultati e i recenti punti salienti dell'attività.
Gli investitori e le parti interessate possono accedere alla chiamata componendo il numero (800) 715-9871 (USA e Canada - Numero Verde) e inserendo il Codice Conferenza: 4155557. Inoltre, sarà disponibile una diretta streaming della chiamata in conferenza attraverso la sezione Investitori del sito web di Akebia all'indirizzo https://ir.akebia.com/. Anche un archivio online della diretta sarà accessibile tramite la stessa sezione del sito dell'azienda.
Akebia Therapeutics (Nasdaq: AKBA) ha anunciado planes para publicar sus resultados financieros del segundo trimestre de 2024 el jueves 8 de agosto de 2024, antes de la apertura de los mercados financieros. La empresa llevará a cabo una llamada en conferencia a las 8:00 a.m. ET el mismo día para discutir los resultados y los aspectos destacados recientes del negocio.
Los inversores y partes interesadas pueden acceder a la llamada marcando el (800) 715-9871 (EE. UU. y Canadá - Gratis) e ingresando el ID de Conferencia: 4155557. Adicionalmente, se dispondrá de un webcast en vivo de la llamada en conferencia a través de la sección de Inversores del sitio web de Akebia en https://ir.akebia.com/. También habrá un archivo en línea del webcast disponible a través de la misma sección del sitio web de la empresa.
Akebia Therapeutics (Nasdaq: AKBA)는 2024년 2분기 재무 결과를 2024년 8월 8일 목요일, 금융 시장이 열리기 전에 발표할 계획을 발표했습니다. 회사는 같은 날 동부 표준시 오전 8시에 결과 및 최근 비즈니스 주요 사항에 대해 논의하는 컨퍼런스 콜를 개최합니다.
투자자 및 관심 있는 분들은 (800) 715-9871 (미국 및 캐나다 - 무료)로 전화하여 회의 ID: 4155557을 입력하면 통화에 참여할 수 있습니다. 또한 Akebia의 웹사이트 투자자 섹션(https://ir.akebia.com/)을 통해 실시간 웹캐스트를 이용할 수 있습니다. 회사 웹사이트의 동일한 섹션을 통해 웹캐스트의 온라인 아카이브에도 액세스할 수 있습니다.
Akebia Therapeutics (Nasdaq: AKBA) a annoncé ses projets de publication de ses résultats financiers pour le deuxième trimestre de 2024 le jeudi 8 août 2024, avant l'ouverture des marchés financiers. L'entreprise organisera une conférence téléphonique à 8h00 ET le même jour pour discuter des résultats et des points saillants récents de l'activité.
Les investisseurs et les parties intéressées peuvent accéder à l'appel en composant le (800) 715-9871 (États-Unis et Canada - Numéro vert) et en entrant l'ID de la conférence : 4155557. De plus, un webinaire en direct de l'appel de conférence sera disponible dans la section Investisseurs du site Web d'Akebia à l'adresse https://ir.akebia.com/. Un archive en ligne du webinaire sera également accessible via la même section du site de l'entreprise.
Akebia Therapeutics (Nasdaq: AKBA) hat Pläne angekündigt, die Finanzergebnisse für das zweite Quartal 2024 am Donnerstag, den 8. August 2024, vor der Öffnung der Finanzmärkte zu veröffentlichen. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Konferenzschaltung abhalten, um die Ergebnisse und aktuelle Geschäftshighlights zu diskutieren.
Investoren und interessierte Parteien können über die Nummer (800) 715-9871 (USA & Kanada - gebührenfrei) in die Konferenzschaltung einwählen und die Konferenz-ID: 4155557 eingeben. Zusätzlich wird ein Live-Webcast der Konferenzschaltung über den Bereich „Investoren“ der Akebia-Website unter https://ir.akebia.com/ verfügbar sein. Ein Online-Archiv des Webcasts wird ebenfalls über denselben Bereich der Unternehmenswebsite zugänglich sein.
- None.
- None.
Akebia to Host Conference Call on August 8, 2024, at 8:00 a.m. ET
Akebia will host a conference call on Thursday, August 8, 2024, at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call, please dial (800) 715-9871 (
A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-2024-financial-results-and-discuss-recent-business-highlights-302213120.html
SOURCE Akebia Therapeutics, Inc.
FAQ
When will Akebia Therapeutics (AKBA) report its Q2 2024 financial results?
What time is Akebia Therapeutics' (AKBA) Q2 2024 earnings conference call?
How can investors access Akebia Therapeutics' (AKBA) Q2 2024 earnings call?
Where can I find the webcast of Akebia Therapeutics' (AKBA) Q2 2024 earnings call?
